A multicenter, prospective, open label, randomized, controlled phase IIIb study of SH U 508a (Levovist) for Doppler signal enhancement in the portal vascular system. - Gebel,M.; Caelitz,M.; Bowen-Davis,P.E.; Weber,S. (Ultraschall Med, 1998)